The effect of continuous subcutaneous insulin infusion on insulin binding to erythrocytes in diabetes mellitus

Frank M. Ng, Erol Babacan, Matthew Cohen, Paul Z. Zimmet

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The effect of continuous subcutaneous insulin infusion (CSII) on glycaemic control and insulin binding to erythrocytes was studied in six diabetic patients. A marked improvement in blood glucose control during CSII was observed in these patients previously on conventional therapy. Specific 125I-insulin binding to erythrocytes of the diabetics before the institution of CSII was significantly lower than that of age-, weight- and sex-matched nondiabetic subjects, 6.5 ± 0.1% vs. 9.8 ± 0.3% (P < 0.05). After 4-6 months of CSII, insulin binding was restored to normal levels. This normalization in insulin binding to erythrocytes of patients on CSII was due to a 35% increase in active binding sites, together with a small change in binding affinity.

LanguageEnglish
Pages31-37
Number of pages7
JournalDiabetes Research and Clinical Practice
Volume3
Issue number1
DOIs
Publication statusPublished - 1987

Keywords

  • (Diabetes mellitus)
  • Continuous subcutaneous insulin infusion
  • Erythrocyte
  • Insulin binding

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Ng, Frank M. ; Babacan, Erol ; Cohen, Matthew ; Zimmet, Paul Z. / The effect of continuous subcutaneous insulin infusion on insulin binding to erythrocytes in diabetes mellitus. In: Diabetes Research and Clinical Practice. 1987 ; Vol. 3, No. 1. pp. 31-37.
@article{7837c951ec3a4963bd174c57267c2069,
title = "The effect of continuous subcutaneous insulin infusion on insulin binding to erythrocytes in diabetes mellitus",
abstract = "The effect of continuous subcutaneous insulin infusion (CSII) on glycaemic control and insulin binding to erythrocytes was studied in six diabetic patients. A marked improvement in blood glucose control during CSII was observed in these patients previously on conventional therapy. Specific 125I-insulin binding to erythrocytes of the diabetics before the institution of CSII was significantly lower than that of age-, weight- and sex-matched nondiabetic subjects, 6.5 ± 0.1{\%} vs. 9.8 ± 0.3{\%} (P < 0.05). After 4-6 months of CSII, insulin binding was restored to normal levels. This normalization in insulin binding to erythrocytes of patients on CSII was due to a 35{\%} increase in active binding sites, together with a small change in binding affinity.",
keywords = "(Diabetes mellitus), Continuous subcutaneous insulin infusion, Erythrocyte, Insulin binding",
author = "Ng, {Frank M.} and Erol Babacan and Matthew Cohen and Zimmet, {Paul Z.}",
year = "1987",
doi = "10.1016/S0168-8227(87)80005-0",
language = "English",
volume = "3",
pages = "31--37",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

The effect of continuous subcutaneous insulin infusion on insulin binding to erythrocytes in diabetes mellitus. / Ng, Frank M.; Babacan, Erol; Cohen, Matthew; Zimmet, Paul Z.

In: Diabetes Research and Clinical Practice, Vol. 3, No. 1, 1987, p. 31-37.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effect of continuous subcutaneous insulin infusion on insulin binding to erythrocytes in diabetes mellitus

AU - Ng, Frank M.

AU - Babacan, Erol

AU - Cohen, Matthew

AU - Zimmet, Paul Z.

PY - 1987

Y1 - 1987

N2 - The effect of continuous subcutaneous insulin infusion (CSII) on glycaemic control and insulin binding to erythrocytes was studied in six diabetic patients. A marked improvement in blood glucose control during CSII was observed in these patients previously on conventional therapy. Specific 125I-insulin binding to erythrocytes of the diabetics before the institution of CSII was significantly lower than that of age-, weight- and sex-matched nondiabetic subjects, 6.5 ± 0.1% vs. 9.8 ± 0.3% (P < 0.05). After 4-6 months of CSII, insulin binding was restored to normal levels. This normalization in insulin binding to erythrocytes of patients on CSII was due to a 35% increase in active binding sites, together with a small change in binding affinity.

AB - The effect of continuous subcutaneous insulin infusion (CSII) on glycaemic control and insulin binding to erythrocytes was studied in six diabetic patients. A marked improvement in blood glucose control during CSII was observed in these patients previously on conventional therapy. Specific 125I-insulin binding to erythrocytes of the diabetics before the institution of CSII was significantly lower than that of age-, weight- and sex-matched nondiabetic subjects, 6.5 ± 0.1% vs. 9.8 ± 0.3% (P < 0.05). After 4-6 months of CSII, insulin binding was restored to normal levels. This normalization in insulin binding to erythrocytes of patients on CSII was due to a 35% increase in active binding sites, together with a small change in binding affinity.

KW - (Diabetes mellitus)

KW - Continuous subcutaneous insulin infusion

KW - Erythrocyte

KW - Insulin binding

UR - http://www.scopus.com/inward/record.url?scp=0023148750&partnerID=8YFLogxK

U2 - 10.1016/S0168-8227(87)80005-0

DO - 10.1016/S0168-8227(87)80005-0

M3 - Article

VL - 3

SP - 31

EP - 37

JO - Diabetes Research and Clinical Practice

T2 - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 1

ER -